All maternity providers across England are now offering non-invasive prenatal testing (NIPT) as part of the existing NHS screening pathway for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome.
NHS Fetal Anomaly Screening Programme
The research advisory committee (RAC) reviews applications to carry out research involving NHS screening programme participants or requiring access to screening data or samples.
We (PHE Screening, and NHS England and NHS Improvement) want to take a moment to recognise the huge contribution of all staff who work so hard to deliver the NHS antenatal and newborn screening programmes.
Non-invasive prenatal testing (NIPT) was today added to the existing NHS screening pathway for Down’s syndrome, Edwards’ syndrome and Patau’s syndrome.
PHE Screening has today published new operational guidance on non-invasive prenatal testing (NIPT), which will be added to the existing NHS screening programme for Down's syndrome, Edwards' syndrome and Patau's syndrome as part of an evaluative rollout from 1 June 2021.
New simple A4 printable PDF versions of 6 of the most commonly used ANNB screening publications.
An 8-week consultation on proposed changes to the standards opens today.
How PHE developed the public information and professional education and training resources to support the implementation of NIPT in the NHS screening pathway for Down's syndrome, Edwards' syndrome and Patau's syndrome.
Updated letter templates for antenatal screening laboratories to use when providing lower chance results to women following a combined or quadruple screening test.
We've published 7 new screening animations explaining the different screening tests for pregnant women and newborn babies.